ANKTIVA ® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product ImmunityBio’s 400,000 square foot GMP fill-finish facility in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Los Angeles-based company is far different from Athenex ...

As it continues construction, ImmunityBio noted in a quarterly regulatory filing that it believes governmental funding will assist in funding a portion of the further build-out in Dunkirk. As of March ...

The 409,000-square-foot Athenex facility is located off Route 5 in the town of Dunkirk. ImmunityBio, Inc., a clinical-stage immunotherapy company, announced Tuesday it has completed acquisition of the ...

DUNKIRK, N.Y. — ImmunityBio has filed a WARN notice with the New York state Department of Labor for two layoffs at its plant in Dunkirk. According to the notice, the California-based biopharmaceutical ...

OBSERVER Photo by Braden Carmen ImmunityBio took over the former Athenex plant in February. DUNKIRK — Citing “construction needs” at what was described just years ago as a state-of-the-art facility, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min “Following in-depth review, we ...

ImmunityBio’s push to hire 300 people at its New York facility in 30 months has made a bad start. Rather than add to its head count, Patrick Soon-Shiong’s biotech has outlined plans to lay off 38 ...

DUNKIRK, N.Y. (WKBW) — Layoffs are coming for nearly 40 employees at ImmunityBio, a late-clinical-stage immunotherapy company in Dunkirk. According to a WARN notice filed on September 29, the facility ...

As it continues construction, ImmunityBio noted in a quarterly regulatory filing that it believes governmental funding will assist in funding a portion of the further build-out in Dunkirk. As of March ...